HRI Herc Holdings reports robust Q4 2025 results with 8 percent EPS beat and 283 percent year over year revenue growth Barclays iPath Series B SP 500 VIX ShortTerm Futures ETN VXX Geopolitical Risk Pricing Unlocks Entry Points for BeatenDown Equity ETFs JAGX Jaguar Health posts wider than expected Q3 2025 loss and slight year over year revenue dip with shares climbing slightly today What makes Calamos Fund CHY a stronger buy than it appears Momentum Building 20260511 Greenidge GREEL Q1 loss narrows 44 more than expected shares dip slightly despite earnings beat SCHL Q1 2026 Earnings NarrowerThanExpected Loss Lifts Sentiment Under Armour Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Restructuring CE Q1 2026 Earnings EPS Misses Estimates by 46 Stock Gains 107 GPCR Q1 2026 Earnings EPS Beat Drives Modest Stock Gain as PreRevenue Biotech Advances Pipeline TCPC Q1 2026 Earnings EPS Beats Estimates by Over 10 AARD Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress